| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | ACTINOBAC BIOMED, INC. | 15 PELHAM RD | KENDALL PARK | NJ | 08824-1309 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 000 | 3 | NIH | 2/21/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $140,000 ) |
| | 2016 | 2016 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 002 | 3 | NIH | 9/16/2016 | $140,000 |
| | 2016 | 2015 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 001 | 3 | NIH | 9/15/2016 | -$140,000 |
| | 2016 | 2015 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 000 | 3 | NIH | 9/14/2016 | $140,000 |
|
| Issue Date FY: 2015 ( Subtotal = $894,222 ) |
| | 2015 | 2015 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 000 | 3 | NIH | 8/24/2015 | $894,222 |
|
| Issue Date FY: 2014 ( Subtotal = $905,040 ) |
| | 2014 | 2014 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 000 | 2 | NIH | 9/26/2014 | $38,487 |
| | 2014 | 2014 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R42CA173900 | Targeting B-cell lymphoma with Leukothera-phase II | 000 | 2 | NIH | 9/26/2014 | $866,553 |
|
| Issue Date FY: 2013 ( Subtotal = $108,255 ) |
| | 2013 | 2013 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R41CA173900 | TARGETING B-CELL LYMPHOMA WITH LEUKOTHERA | 000 | 1 | NIH | 8/8/2013 | $108,255 |
|
| Issue Date FY: 2012 ( Subtotal = $202,601 ) |
| | 2012 | 2012 | ACTINOBAC BIOMED INC | 15 PELHAM ROAD | KENDALL PARK | NJ | 08824 | MIDDLESEX | USA | R41CA173900 | TARGETING B-CELL LYMPHOMA WITH LEUKOTHERA | 000 | 1 | NIH | 9/26/2012 | $202,601 |
|
|
